FAM90A4P

Across TCGA pan-cancer cohorts, FAM90A4P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated FAM90A4P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher FAM90A4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A4P expression acts as an unfavorable survival marker.

MESO, KIRC, and ESCA are the cancer types where FAM90A4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.036	0.602	<.001	126	view →
KIRC	OS	Tertile	All	0.138	0.655	.021	36	view →
ESCA	OS	Tertile	II,III,IV	0.248	0.686	.019	27	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FAM90A4P–MESO (OS)

Open the MESO breakdown →